HARBOUR BIOMED RECEIVES CHINA NMPA APPROVAL OF BATOCLIMAB INJECTION (SUBCUTANEOUS INJECTION) FOR THE TREATMENT OF GENERALIZED MYASTHENIA GRAVIS

Reuters · 3d ago

Please log in to view news